Global Antithrombin Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Antithrombin Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Liquid
  • 1.2.3 Lyophilized
• 1.3 Market by Application
  • 1.3.1 Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Diagnostics
  • 1.3.3 Therapeutics
  • 1.3.4 Research
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Antithrombin Sales Estimates and Forecasts 2017-2028
• 2.2 Global Antithrombin Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Antithrombin Sales by Region
  • 2.4.1 Global Antithrombin Sales by Region (2017-2022)
  • 2.4.2 Global Sales Antithrombin by Region (2023-2028)
• 2.5 Global Antithrombin Revenue by Region
  • 2.5.1 Global Antithrombin Revenue by Region (2017-2022)
  • 2.5.2 Global Antithrombin Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Antithrombin Sales by Manufacturers
  • 3.1.1 Global Top Antithrombin Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Antithrombin Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antithrombin in 2021
• 3.2 Global Antithrombin Revenue by Manufacturers
  • 3.2.1 Global Antithrombin Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Antithrombin Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Antithrombin Revenue in 2021
• 3.3 Global Antithrombin Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Antithrombin Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Antithrombin Sales by Type
  • 4.1.1 Global Antithrombin Historical Sales by Type (2017-2022)
  • 4.1.2 Global Antithrombin Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Antithrombin Sales Market Share by Type (2017-2028)
• 4.2 Global Antithrombin Revenue by Type
  • 4.2.1 Global Antithrombin Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Antithrombin Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Antithrombin Revenue Market Share by Type (2017-2028)
• 4.3 Global Antithrombin Price by Type
  • 4.3.1 Global Antithrombin Price by Type (2017-2022)
  • 4.3.2 Global Antithrombin Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Antithrombin Sales by Application
  • 5.1.1 Global Antithrombin Historical Sales by Application (2017-2022)
  • 5.1.2 Global Antithrombin Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Antithrombin Sales Market Share by Application (2017-2028)
• 5.2 Global Antithrombin Revenue by Application
  • 5.2.1 Global Antithrombin Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Antithrombin Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Antithrombin Revenue Market Share by Application (2017-2028)
• 5.3 Global Antithrombin Price by Application
  • 5.3.1 Global Antithrombin Price by Application (2017-2022)
  • 5.3.2 Global Antithrombin Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Antithrombin Market Size by Type
  • 6.1.1 North America Antithrombin Sales by Type (2017-2028)
  • 6.1.2 North America Antithrombin Revenue by Type (2017-2028)
• 6.2 North America Antithrombin Market Size by Application
  • 6.2.1 North America Antithrombin Sales by Application (2017-2028)
  • 6.2.2 North America Antithrombin Revenue by Application (2017-2028)
• 6.3 North America Antithrombin Market Size by Country
  • 6.3.1 North America Antithrombin Sales by Country (2017-2028)
  • 6.3.2 North America Antithrombin Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Antithrombin Market Size by Type
  • 7.1.1 Europe Antithrombin Sales by Type (2017-2028)
  • 7.1.2 Europe Antithrombin Revenue by Type (2017-2028)
• 7.2 Europe Antithrombin Market Size by Application
  • 7.2.1 Europe Antithrombin Sales by Application (2017-2028)
  • 7.2.2 Europe Antithrombin Revenue by Application (2017-2028)
• 7.3 Europe Antithrombin Market Size by Country
  • 7.3.1 Europe Antithrombin Sales by Country (2017-2028)
  • 7.3.2 Europe Antithrombin Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Antithrombin Market Size by Type
  • 8.1.1 Asia Pacific Antithrombin Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Antithrombin Revenue by Type (2017-2028)
• 8.2 Asia Pacific Antithrombin Market Size by Application
  • 8.2.1 Asia Pacific Antithrombin Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Antithrombin Revenue by Application (2017-2028)
• 8.3 Asia Pacific Antithrombin Market Size by Region
  • 8.3.1 Asia Pacific Antithrombin Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Antithrombin Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Antithrombin Market Size by Type
  • 9.1.1 Latin America Antithrombin Sales by Type (2017-2028)
  • 9.1.2 Latin America Antithrombin Revenue by Type (2017-2028)
• 9.2 Latin America Antithrombin Market Size by Application
  • 9.2.1 Latin America Antithrombin Sales by Application (2017-2028)
  • 9.2.2 Latin America Antithrombin Revenue by Application (2017-2028)
• 9.3 Latin America Antithrombin Market Size by Country
  • 9.3.1 Latin America Antithrombin Sales by Country (2017-2028)
  • 9.3.2 Latin America Antithrombin Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Antithrombin Market Size by Type
  • 10.1.1 Middle East and Africa Antithrombin Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Antithrombin Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Antithrombin Market Size by Application
  • 10.2.1 Middle East and Africa Antithrombin Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Antithrombin Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Antithrombin Market Size by Country
  • 10.3.1 Middle East and Africa Antithrombin Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Antithrombin Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Grifols
  • 11.1.1 Grifols Corporation Information
  • 11.1.2 Grifols Overview
  • 11.1.3 Grifols Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Grifols Recent Developments
• 11.2 rEVO Biologics Inc.
  • 11.2.1 rEVO Biologics Inc. Corporation Information
  • 11.2.2 rEVO Biologics Inc. Overview
  • 11.2.3 rEVO Biologics Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 rEVO Biologics Inc. Recent Developments
• 11.3 Takeda
  • 11.3.1 Takeda Corporation Information
  • 11.3.2 Takeda Overview
  • 11.3.3 Takeda Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Takeda Recent Developments
• 11.4 Kedrion S.p.A.
  • 11.4.1 Kedrion S.p.A. Corporation Information
  • 11.4.2 Kedrion S.p.A. Overview
  • 11.4.3 Kedrion S.p.A. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Kedrion S.p.A. Recent Developments
• 11.5 CSL Limited
  • 11.5.1 CSL Limited Corporation Information
  • 11.5.2 CSL Limited Overview
  • 11.5.3 CSL Limited Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 CSL Limited Recent Developments
• 11.6 Scripps Laboratories Inc.
  • 11.6.1 Scripps Laboratories Inc. Corporation Information
  • 11.6.2 Scripps Laboratories Inc. Overview
  • 11.6.3 Scripps Laboratories Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Scripps Laboratories Inc. Recent Developments
• 11.7 Lee Biosolutions
  • 11.7.1 Lee Biosolutions Corporation Information
  • 11.7.2 Lee Biosolutions Overview
  • 11.7.3 Lee Biosolutions Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Lee Biosolutions Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Antithrombin Industry Chain Analysis
• 12.2 Antithrombin Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Antithrombin Production Mode & Process
• 12.4 Antithrombin Sales and Marketing
  • 12.4.1 Antithrombin Sales Channels
  • 12.4.2 Antithrombin Distributors
• 12.5 Antithrombin Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Antithrombin Industry Trends
• 13.2 Antithrombin Market Drivers
• 13.3 Antithrombin Market Challenges
• 13.4 Antithrombin Market Restraints

14 Key Findings in The Global Antithrombin Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Liquid
• Table 3. Major Manufacturers of Lyophilized
• Table 4. Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Antithrombin Sales by Region (2017-2022) & (Units)
• Table 7. Global Antithrombin Sales Market Share by Region (2017-2022)
• Table 8. Global Antithrombin Sales by Region (2023-2028) & (Units)
• Table 9. Global Antithrombin Sales Market Share by Region (2023-2028)
• Table 10. Global Antithrombin Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Antithrombin Revenue Market Share by Region (2017-2022)
• Table 12. Global Antithrombin Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Antithrombin Revenue Market Share by Region (2023-2028)
• Table 14. Global Antithrombin Sales by Manufacturers (2017-2022) & (Units)
• Table 15. Global Antithrombin Sales Share by Manufacturers (2017-2022)
• Table 16. Global Antithrombin Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Antithrombin Revenue Share by Manufacturers (2017-2022)
• Table 18. Antithrombin Price by Manufacturers (2017-2022) &(US$/Unit)
• Table 19. Global Antithrombin Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Antithrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2021)
• Table 21. Antithrombin Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Antithrombin Product Offered
• Table 23. Date of Manufacturers Enter into Antithrombin Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Antithrombin Sales by Type (2017-2022) & (Units)
• Table 26. Global Antithrombin Sales by Type (2023-2028) & (Units)
• Table 27. Global Antithrombin Sales Share by Type (2017-2022)
• Table 28. Global Antithrombin Sales Share by Type (2023-2028)
• Table 29. Global Antithrombin Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Antithrombin Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Antithrombin Revenue Share by Type (2017-2022)
• Table 32. Global Antithrombin Revenue Share by Type (2023-2028)
• Table 33. Antithrombin Price by Type (2017-2022) & (US$/Unit)
• Table 34. Global Antithrombin Price Forecast by Type (2023-2028) & (US$/Unit)
• Table 35. Global Antithrombin Sales by Application (2017-2022) & (Units)
• Table 36. Global Antithrombin Sales by Application (2023-2028) & (Units)
• Table 37. Global Antithrombin Sales Share by Application (2017-2022)
• Table 38. Global Antithrombin Sales Share by Application (2023-2028)
• Table 39. Global Antithrombin Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Antithrombin Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Antithrombin Revenue Share by Application (2017-2022)
• Table 42. Global Antithrombin Revenue Share by Application (2023-2028)
• Table 43. Antithrombin Price by Application (2017-2022) & (US$/Unit)
• Table 44. Global Antithrombin Price Forecast by Application (2023-2028) & (US$/Unit)
• Table 45. North America Antithrombin Sales by Type (2017-2022) & (Units)
• Table 46. North America Antithrombin Sales by Type (2023-2028) & (Units)
• Table 47. North America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Antithrombin Sales by Application (2017-2022) & (Units)
• Table 50. North America Antithrombin Sales by Application (2023-2028) & (Units)
• Table 51. North America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Antithrombin Sales by Country (2017-2022) & (Units)
• Table 54. North America Antithrombin Sales by Country (2023-2028) & (Units)
• Table 55. North America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Antithrombin Sales by Type (2017-2022) & (Units)
• Table 58. Europe Antithrombin Sales by Type (2023-2028) & (Units)
• Table 59. Europe Antithrombin Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Antithrombin Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Antithrombin Sales by Application (2017-2022) & (Units)
• Table 62. Europe Antithrombin Sales by Application (2023-2028) & (Units)
• Table 63. Europe Antithrombin Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Antithrombin Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Antithrombin Sales by Country (2017-2022) & (Units)
• Table 66. Europe Antithrombin Sales by Country (2023-2028) & (Units)
• Table 67. Europe Antithrombin Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Antithrombin Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Antithrombin Sales by Type (2017-2022) & (Units)
• Table 70. Asia Pacific Antithrombin Sales by Type (2023-2028) & (Units)
• Table 71. Asia Pacific Antithrombin Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Antithrombin Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Antithrombin Sales by Application (2017-2022) & (Units)
• Table 74. Asia Pacific Antithrombin Sales by Application (2023-2028) & (Units)
• Table 75. Asia Pacific Antithrombin Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Antithrombin Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Antithrombin Sales by Region (2017-2022) & (Units)
• Table 78. Asia Pacific Antithrombin Sales by Region (2023-2028) & (Units)
• Table 79. Asia Pacific Antithrombin Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Antithrombin Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Antithrombin Sales by Type (2017-2022) & (Units)
• Table 82. Latin America Antithrombin Sales by Type (2023-2028) & (Units)
• Table 83. Latin America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Antithrombin Sales by Application (2017-2022) & (Units)
• Table 86. Latin America Antithrombin Sales by Application (2023-2028) & (Units)
• Table 87. Latin America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Antithrombin Sales by Country (2017-2022) & (Units)
• Table 90. Latin America Antithrombin Sales by Country (2023-2028) & (Units)
• Table 91. Latin America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Antithrombin Sales by Type (2017-2022) & (Units)
• Table 94. Middle East and Africa Antithrombin Sales by Type (2023-2028) & (Units)
• Table 95. Middle East and Africa Antithrombin Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Antithrombin Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Antithrombin Sales by Application (2017-2022) & (Units)
• Table 98. Middle East and Africa Antithrombin Sales by Application (2023-2028) & (Units)
• Table 99. Middle East and Africa Antithrombin Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Antithrombin Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Antithrombin Sales by Country (2017-2022) & (Units)
• Table 102. Middle East and Africa Antithrombin Sales by Country (2023-2028) & (Units)
• Table 103. Middle East and Africa Antithrombin Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Antithrombin Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Grifols Corporation Information
• Table 106. Grifols Description and Major Businesses
• Table 107. Grifols Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 108. Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Grifols Recent Developments
• Table 110. rEVO Biologics Inc. Corporation Information
• Table 111. rEVO Biologics Inc. Description and Major Businesses
• Table 112. rEVO Biologics Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 113. rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. rEVO Biologics Inc. Recent Developments
• Table 115. Takeda Corporation Information
• Table 116. Takeda Description and Major Businesses
• Table 117. Takeda Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 118. Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Takeda Recent Developments
• Table 120. Kedrion S.p.A. Corporation Information
• Table 121. Kedrion S.p.A. Description and Major Businesses
• Table 122. Kedrion S.p.A. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 123. Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Kedrion S.p.A. Recent Developments
• Table 125. CSL Limited Corporation Information
• Table 126. CSL Limited Description and Major Businesses
• Table 127. CSL Limited Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 128. CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. CSL Limited Recent Developments
• Table 130. Scripps Laboratories Inc. Corporation Information
• Table 131. Scripps Laboratories Inc. Description and Major Businesses
• Table 132. Scripps Laboratories Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 133. Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Scripps Laboratories Inc. Recent Developments
• Table 135. Lee Biosolutions Corporation Information
• Table 136. Lee Biosolutions Description and Major Businesses
• Table 137. Lee Biosolutions Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
• Table 138. Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Lee Biosolutions Recent Developments
• Table 140. Key Raw Materials Lists
• Table 141. Raw Materials Key Suppliers Lists
• Table 142. Antithrombin Distributors List
• Table 143. Antithrombin Customers List
• Table 144. Antithrombin Market Trends
• Table 145. Antithrombin Market Drivers
• Table 146. Antithrombin Market Challenges
• Table 147. Antithrombin Market Restraints
• Table 148. Research Programs/Design for This Report
• Table 149. Key Data Information from Secondary Sources
• Table 150. Key Data Information from Primary Sources

List of Figures

• Figure 1. Antithrombin Product Picture
• Figure 3. Global Antithrombin Market Share by Type in 2021 & 2028
• Figure 3. Liquid Product Picture
• Figure 4. Lyophilized Product Picture
• Figure 5. Global Antithrombin Market Share by Application in 2021 & 2028
• Figure 6. Diagnostics
• Figure 7. Therapeutics
• Figure 8. Research
• Figure 9. Antithrombin Report Years Considered
• Figure 10. Global Antithrombin Sales 2017-2028 (Units)
• Figure 11. Global Antithrombin Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Antithrombin Revenue 2017-2028 (US$ Million)
• Figure 13. Global Antithrombin Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Antithrombin Sales Market Share by Region (2017-2022)
• Figure 15. Global Antithrombin Sales Market Share by Region (2023-2028)
• Figure 16. North America Antithrombin Sales YoY (2017-2028) & (Units)
• Figure 17. North America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Antithrombin Sales YoY (2017-2028) & (Units)
• Figure 19. Europe Antithrombin Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Antithrombin Sales YoY (2017-2028) & (Units)
• Figure 21. Asia-Pacific Antithrombin Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Antithrombin Sales YoY (2017-2028) & (Units)
• Figure 23. Latin America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Antithrombin Sales YoY (2017-2028) & (Units)
• Figure 25. Middle East & Africa Antithrombin Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Antithrombin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Antithrombin in the World: Market Share by Antithrombin Revenue in 2021
• Figure 28. Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Antithrombin Sales Market Share by Type (2017-2028)
• Figure 30. Global Antithrombin Revenue Market Share by Type (2017-2028)
• Figure 31. Global Antithrombin Sales Market Share by Application (2017-2028)
• Figure 32. Global Antithrombin Revenue Market Share by Application (2017-2028)
• Figure 33. North America Antithrombin Sales Market Share by Type (2017-2028)
• Figure 34. North America Antithrombin Revenue Market Share by Type (2017-2028)
• Figure 35. North America Antithrombin Sales Market Share by Application (2017-2028)
• Figure 36. North America Antithrombin Revenue Market Share by Application (2017-2028)
• Figure 37. North America Antithrombin Sales Share by Country (2017-2028)
• Figure 38. North America Antithrombin Revenue Share by Country (2017-2028)
• Figure 39. U.S. Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Antithrombin Sales Market Share by Type (2017-2028)
• Figure 42. Europe Antithrombin Revenue Market Share by Type (2017-2028)
• Figure 43. Europe Antithrombin Sales Market Share by Application (2017-2028)
• Figure 44. Europe Antithrombin Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Antithrombin Sales Share by Country (2017-2028)
• Figure 46. Europe Antithrombin Revenue Share by Country (2017-2028)
• Figure 47. Germany Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 48. France Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 49. U.K. Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Antithrombin Sales Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Antithrombin Revenue Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Antithrombin Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Antithrombin Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Antithrombin Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Antithrombin Revenue Share by Region (2017-2028)
• Figure 58. China Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 61. India Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 63. Taiwan Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 67. Philippines Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 68. Latin America Antithrombin Sales Market Share by Type (2017-2028)
• Figure 69. Latin America Antithrombin Revenue Market Share by Type (2017-2028)
• Figure 70. Latin America Antithrombin Sales Market Share by Application (2017-2028)
• Figure 71. Latin America Antithrombin Revenue Market Share by Application (2017-2028)
• Figure 72. Latin America Antithrombin Sales Share by Country (2017-2028)
• Figure 73. Latin America Antithrombin Revenue Share by Country (2017-2028)
• Figure 74. Mexico Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 75. Brazil Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 76. Argentina Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 77. Middle East and Africa Antithrombin Sales Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Antithrombin Revenue Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Antithrombin Sales Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Antithrombin Revenue Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Antithrombin Sales Share by Country (2017-2028)
• Figure 82. Middle East and Africa Antithrombin Revenue Share by Country (2017-2028)
• Figure 83. Turkey Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 84. Saudi Arabia Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 85. UAE Antithrombin Revenue (2017-2028) & (US$ Million)
• Figure 86. Antithrombin Value Chain
• Figure 87. Antithrombin Production Process
• Figure 88. Channels of Distribution
• Figure 89. Distributors Profiles
• Figure 90. Bottom-up and Top-down Approaches for This Report
• Figure 91. Data Triangulation
• Figure 92. Key Executives Interviewed